Discrete Early Pro-B and Pre-B Stages in Normal Human Bone Marrow As Defined by Surface Pseudo-light Chain Expression
Overview
Authors
Affiliations
Vpre-B and lambda-like genes are selectively expressed in B cell precursors and encode polypeptide chains associated in a mu-pseudo light chain (mu-psi L) complex which is thought to regulate some early steps of B cell differentiation. We have generated anti-Vpre-B monoclonal antibodies which allowed us to identify different steps of differentiation from the pro-B to the immature B cells by following surface expression of Vpre-B, mu and light chains in normal adult human bone marrow. Already present at the surface of a small fraction of B cell progenitors (CD34+/CD19+) the Vpre-B molecule was consistently found coexpressed with CD19 and was also found with the sequentially occurring CD10, CD20, CD21, CD22 and CD5 markers. Three discrete cell types were identified: (i) a subpopulation expressing Vpre-B without mu and which represented an early stage of differentiation, (ii) a minor subpopulation co-expressing Vpre-B and mu without the conventional light chains and (iii) a major subpopulation co-expressing Vpre-B, mu and kappa or lambda chains, considered an intermediate pre-B/B stage. The presence of the psi L chain in various cell subpopulations, in possible association with discrete molecules and/or different contexts, suggests its involvement at several steps of early B cell differentiation.
Kaku H, Holodick N, Tumang J, Rothstein T Front Immunol. 2017; 8:672.
PMID: 28676801 PMC: 5477345. DOI: 10.3389/fimmu.2017.00672.
Mutations in Igalpha (CD79a) result in a complete block in B-cell development.
Minegishi Y, Coustan-Smith E, Rapalus L, Ersoy F, Campana D, Conley M J Clin Invest. 1999; 104(8):1115-21.
PMID: 10525050 PMC: 408581. DOI: 10.1172/JCI7696.
Ghia P, Ten Boekel E, Sanz E, de la Hera A, Rolink A, Melchers F J Exp Med. 1996; 184(6):2217-29.
PMID: 8976177 PMC: 2196361. DOI: 10.1084/jem.184.6.2217.
Meffre E, Ledeist F, de Saint-Basile G, Deville A, Fougereau M, Fischer A J Clin Invest. 1996; 98(7):1519-26.
PMID: 8833898 PMC: 507582. DOI: 10.1172/JCI118943.
Sanz E, de la Hera A J Exp Med. 1996; 183(6):2693-8.
PMID: 8676092 PMC: 2192595. DOI: 10.1084/jem.183.6.2693.